Literature DB >> 24412119

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.

Jessica N McAlpine1, Gillian E Hanley2, Michelle M M Woo3, Alicia A Tone4, Nirit Rozenberg5, Kenneth D Swenerton6, C Blake Gilks7, Sarah J Finlayson8, David G Huntsman3, Dianne M Miller8.   

Abstract

OBJECTIVE: The purpose of this study was to assess the uptake and perioperative safety of bilateral salpingectomy (BS) as an ovarian cancer risk-reduction strategy in low-risk women after a regional initiative that was aimed at general gynecologists in the province of British Columbia, Canada. STUDY
DESIGN: This population-based retrospective cohort study evaluated 43,931 women in British Columbia from 2008-2011 who underwent hysterectomy that was performed with and without BS or bilateral salpingo-oophorectomy or who underwent surgical sterilization by means of BS or tubal ligation. Parameters that were examined include patient age, operating time, surgical approach, indication, length of hospital stay, and perioperative complications.
RESULTS: There was an increase in the uptake of hysterectomy with BS (5-35%; P < .001) and BS for sterilization (0.5-33%; P < .001) over the study period, particularly in women <50 years old. Minimal additional surgical time is required for hysterectomy with BS (16 minutes; P < .001) and BS for sterilization (10 minutes; P < .001) compared with hysterectomy alone or tubal ligation, respectively. No significant differences were observed in the risks of hospital readmission or blood transfusions in women who underwent hysterectomy with BS (adjusted odds ratio [aOR], 0.91; 95% confidence interval [CI], 0.75-1.10; and aOR, 0.86; 95% CI, 0.67-1.10, respectively) or BS for sterilization (aOR, 0.8; 95% CI, 0.56-1.21; and aOR, 0.75; 95% CI, 0.32-1.73, respectively). From 2008-2011 the proportion of hysterectomies with BS performed by open laparotomy decreased from 77-44% with uptake in laparoscopic, vaginal, and combined procedures (P < .001).
CONCLUSION: After our 2010 educational initiative, there has been a shift in surgical paradigm in our province. This cancer prevention approach does not increase the risk of operative/perioperative complications and appears both feasible and safe.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  educational campaign; ovarian cancer; prevention; safety; salpingectomy

Mesh:

Year:  2014        PMID: 24412119     DOI: 10.1016/j.ajog.2014.01.003

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  57 in total

1.  The Fallopian Tube in the 21st Century: When, Why, and How to Consider Removal.

Authors:  Roberta Venturella; Michele Morelli; Fulvio Zullo
Journal:  Oncologist       Date:  2015-09-17

Review 2.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

Authors:  Ruth Perets; Ronny Drapkin
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

3.  Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.

Authors:  Akila Subramaniam; Christina T Blanchard; Britt K Erickson; Jeff Szychowski; Charles A Leath; Joseph R Biggio; Warner K Huh
Journal:  Obstet Gynecol       Date:  2018-07       Impact factor: 7.661

Review 4.  Ovarian Cancer Prevention in High-risk Women.

Authors:  Sarah M Temkin; Jennifer Bergstrom; Goli Samimi; Lori Minasian
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

5.  Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition.

Authors:  Gery Lamblin; Capucine Meysonnier; Stéphanie Moret; Béatrice Nadaud; Georges Mellier; Gautier Chene
Journal:  Int Urogynecol J       Date:  2017-07-13       Impact factor: 2.894

6.  Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria.

Authors:  F L Potz; G Tomasch; S Polterauer; R Laky; C Marth; K Tamussino
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

Review 7.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

Review 8.  Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.

Authors:  Roi Tschernichovsky; Annekathryn Goodman
Journal:  Oncologist       Date:  2017-03-17

9.  Adnexectomy at the time of vaginal hysterectomy for pelvic organ prolapse.

Authors:  Emily A Slopnick; David D Sheyn; Graham C Chapman; Sangeeta T Mahajan; Sharif El-Nashar; Adonis K Hijaz
Journal:  Int Urogynecol J       Date:  2019-05-21       Impact factor: 2.894

10.  Women's preferences for permanent contraception method and willingness to be randomized for a hypothetical trial.

Authors:  Adriana Piazza; Kelly Schwirian; Fiona Scott; Machelle D Wilson; Nikki B Zite; Mitchell D Creinin
Journal:  Contraception       Date:  2018-09-26       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.